News

Working in an ambulatory surgery center can be a good choice for ophthalmologists, particularly cataract surgeons, because they let them use their time efficiently while delivering excellent care without the hassles of working in a larger hospital setting where ophthalmology may not be a priority.

Ophthalmologists have a choice in dealing with accountable care organizations (ACOs). Take the initiative and work with ACOs, or ignore them, suggests one consultant.

Best-corrected visual acuity does not capture the degree of impairment in some patients, such as those with geographic atrophy, particularly as they try to read across a page. A new patient-reported outcome measure has been found to correlate well with a more objective measurement of performance.

A novel class of drugs ‒ rho-kinase, or ROCK inhibitors ‒ appears to lower IOP by relaxing the trabecular meshwork.

Visual snow is a persistent visual disturbance that is typically described as seeing ‘television static’ throughout the visual field.

A femtosecond laser platform (Victus, Bausch + Lomb) features an enhanced patient interface kit with a smaller outer diameter and other modifications that bring easier handling and centration along with greater stability.

In this Q&A, Ophthalmology Times talks to Michael Repka, MD, MBA and medical director of government affairs for the American Academy of Ophthalmology how the transition to ICD-10 is affecting ophthalmologists.

A software upgrade (Streamline) for the LENSAR Laser System (LENSAR) adds new capabilities for automated data transfer, iris registration, astigmatic correction, and lens analysis and fragmentation that enhance accuracy, efficiency, and outcomes in cataract surgery.

Data from large randomized trials indicate that diabetic macular edema can be treated safely and effectively with anti-vascular endothelial growth factor therapies.

Joint networking event with ASPENS brought together 4 speakers who shared stories about where they find inspiration.

A new wearable adaptive refractor (VisionFit; Adaptica, Padova, Italy) for subjective refraction combines the features of trial frames and manual and automated phoropters. With this mobile device, patients can be examined while sitting or standing, and the unit itself can be easily transported.

The annual “Cataract Surgery: Telling It Like It Is!” meeting has grown so much that after five years, it has had to relocate from Sarasota to Naples, Florida, to accommodate all the attendees and exhibitors.

Whose fault is it for damaging the U.S. healthcare system?

New, highly accurate aberrometer technology is now available for the intraoperative confirmation of spherical, toric, and multifocal IOL power.

Now it may be easier than ever for strabismus surgeons to adopt adjustable sutures thanks to a short tag noose adjustable suture technique that allows for optional suture adjustment.

An anterior segment diagnostic imaging platform based on high-speed swept-source OCT is being developed by Heidelberg Engineering. It will provide biometry as well as corneal topography and tomography, while also enabling visualization of the anterior and posterior lens surfaces and assessment of the anterior chamber angle.

Documenting practice flow and needs is a critical step in preparation for choosing or replacing an electronic health record system.

With glaucoma drainage devices gaining in popularity, the implantation technique must be tweaked to achieve the best results with the fewest complications.

Robert Dempsey, vice president and business unit head at Shire Pharmaceutical’s Ophthalmics Business Unit, recently talked with Ophthalmology Times Group Content Director Mark L. Dlugoss about Shire’s entry into the eye care market. Among the topics discussed are Shire’s attraction to the market, Lifitegrast–its potential dry eye drug, and other potential ophthalmic compounds.

This new use of the word crackle reminds me of a virus because what causes it is often hard to pinpoint; yet, the results are easily seen.

Bruce Allan, MD, UK and David Kang, MD, South Korea, are SCHWIND users for many years. Both greatly appreciate the outstanding performance features offered by the SCHWIND AMARIS excimer laser technology. The company‘s spirit of innovation, their willingness to advance the art and science of refractive surgery, and their responsiveness to feedback. In this video, Dr. Allan and Dr. Kang comment on the sophisticated SCHWIND AMARIS features SmartPulse Technology and TransPRK.

Professor Rudy Nuijts, Professor James Wolffsohn, Dr Mark Cherny and Dr David Frazer share their views on the taboo topic of refractive surprise in cataract surgery. They explain what it means to have a refractive surprise, why they occur, the importance of patient satisfaction and the options available to surgeons (including Rayner Sulcoflex® case studies) when a situation involving a refractive surprise arises.

Professor Marc De Smet talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.

Professor Anat Lowenstein talks about the impact of Ozurdex in treating diabetic macular edema (DME) in the real world clinical setting. This renowned expert in the DME field, explores what the licensing of Ozurdex in DME means to both patients and retinal specialists when treating this potentially blinding condition.